• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Recent advances in the diagnostic evaluation of pancreatic cystic lesions

    2022-03-16 06:22:20DevarshiArdeshnaTroyCaoBrandonRodgersChidiebereOnongayaDanJonesWeiChenEugeneJKoaySomashekarKrishna
    World Journal of Gastroenterology 2022年6期

    Devarshi R Ardeshna,Troy Cao, Brandon Rodgers, Chidiebere Onongaya, Dan Jones, Wei Chen, Eugene JKoay, Somashekar G Krishna

    Abstract Pancreatic cystic lesions (PCLs) are becoming more prevalent due to more frequent abdominal imaging and the increasing age of the general population. It has become crucial to identify these PCLs and subsequently risk stratify them to guide management. Given the high morbidity associated with pancreatic surgery,only those PCLs at high risk for malignancy should undergo such treatment.However, current diagnostic testing is suboptimal at accurately diagnosing and risk stratifying PCLs. Therefore, research has focused on developing new techniques for differentiating mucinous from non-mucinous PCLs and identifying high risk lesions for malignancy. Cross sectional imaging radiomics can potentially improve the predictive accuracy of primary risk stratification of PCLs at the time of detection to guide invasive testing. While cyst fluid glucose has reemerged as a potential biomarker, cyst fluid molecular markers have improved accuracy for identifying specific types of PCLs. Endoscopic ultrasound guided approaches such as confocal laser endomicroscopy and through the needle microforceps biopsy have shown a good correlation with histopathological findings and are evolving techniques for identifying and risk stratifying PCLs.While most of these recent diagnostics are only practiced at selective tertiary care centers, they hold a promise that management of PCLs will only get better in the future.

    Key Words: Pancreatic cystic lesion; Intraductal papillary mucinous neoplasms; Mucinous cystic neoplasm; Microforceps biopsy; Radiomics; Confocal laser endomicroscopy

    INTRODUCTION

    Pancreatic cystic lesions (PCLs) are increasingly detected, largely due to advances in imaging techniques and the increasing age of the general population[1 ]. With prevalence estimated in the range of 4 %-14 % in the general population and increasing constantly, it has become essential to characterize and risk stratify these cysts to guide management[2 ]. Current guidelines for evaluating PCLs are limited to less than optimal diagnostic techniques, resulting in either missed detection of early cancer or surgical over-treatment (see Figure 1 ). Resection of PCLs should be extremely selective since pancreatic surgery generally has a 20 %-40 % morbidity rate and an approximate 2 % mortality rate[3 -5 ]. Therefore, research and utilization of safe and effective diagnostic modalities with high accuracy are needed to evaluate cysts and introduce properly timed interventions.

    Addressing this issue is especially relevant for intraductal papillary mucinous neoplasms (IPMNs), a type of PCL with one of the highest risks for malignancy. Of the two IPMN subtypes, main duct IPMNs are reported to have a risk from 38 % to 68 %and branch duct IPMNs from 12 % to 47 %[6 ]. Substantial research has addressed the use of consensus guidelines for evaluating IPMNs, but all mention that significant areas of improvement is imperative[7 -9 ].

    Current standards for the evaluation of cyst morphology include computed tomography (CT) scan, magnetic resonance imaging (MRI), and endoscopic ultrasound (EUS). Fine needle aspiration (FNA) of cyst fluid for carcinoembryonic antigen (CEA) and cytology is performed during EUS. Considerable heterogeneity exists among the five widely used guidelines, which indicate a lack of standardization in diagnostic workups[7 -12 ]. In terms of the target population, American College of Gastroenterology and European guidelines include all PCLs, American College of Radiology guidelines focus on incidental PCLs, Fukuoka guidelines only focuses on IPMNs and American Gastroenterological Association (AGA) includes all PCLs except main-duct IPMNs. Guidelines differ in recommending evaluation with EUS and EUSFNA, and surgical resection. Multiple studies have compared some of these guidelines for identifying high-risk PCLs. Amongst patients who underwent surgery, the current guidelines directed clinical decision with an accuracy, sensitivity and specificity of 49 .6 %, 23 .5 %, 84 .3 % for 2015 AGA guidelines, 41 .2 %, 39 .7 %, 43 .1 % for revised Fukuoka guidelines and 58 %, 67 .7 %, 45 .1 % for 2018 European guidelines[13 ].

    Figure 1 Current standard of care diagnostic methods are suboptimal in the diagnosis of specific types of pancreatic cystic lesions and risk-stratification of mucinous cysts. PCL: Pancreatic cystic lesion, CEA: Carcinoembryonic antigen, IPMN: Intraductal papillary mucinous neoplasms, MCN:Mucinous cystic neoplasm, SPN: Solid pseudopapillary neoplasm, Cystic-NET: Cystic neuroendocrine tumors, SCA: Serous cystadenoma.

    A better understanding of investigational characteristics that lead to malignancy is necessary to improve existing criteria and accurately determine associated risks(Figure 1 ). While cyst fluid glucose has reemerged as a potential biomarker, novel techniques such as cyst fluid molecular analysis, EUS-guided needle-based confocal laser endomicroscopy (EUS-nCLE) and microforceps biopsy (EUS-MFB) have been introduced. The aim of this review is to provide an update of the recent literature in the management of PCLs with an emphasis on novel diagnostic methods.

    RADIOMICS

    Increasing prevalence of incidental PCLs has placed significant pressure on the necessity of discerning low-risk and high-risk lesions identified in radiological images.Radiomics is the analysis of mathematically derived textural features from crosssectional imaging studies. The features are generally beyond human visual perception.Using radiometric feature extraction tool, radiomics can quantify individual pixels and their associated gray-scale value from cross-sectional imaging in a temporal and spatial plane to create a cyst impression. While studies have varied in the extraction of radiometric data, these features can potentially risk stratify PCLs. Hence, radiomics can guide downstream invasive diagnostics.

    Studies in radiomics can be classified into two broad categories: (1 ) Differentiating types of PCLs, and (2 ) Risk stratification of IPMNs. Investigators have applied machine learning algorithms to radiomic features for automatic classification of PCLs.Some recent studies have evaluated nomograms and algorithms combining radiomics,cyst morphology, and clinical features. For differentiating PCLs, several investigations have demonstrated promising results. One of the first studies by Dmitrievet al[14 ],achieved a reasonable accuracy of 83 .6 % in discriminating PCL types into IPMNs,mucinous cystic neoplasms (MCNs), serous cystadenoma (SCAs) and solid neoplasms[14 ]. Their model had 93 .2 %-95 .9 % accuracy at predicting IPMNs. Subsequently, three investigations utilized CT-Scan radiomics to differentiate serous cystadenomas from other PCLs (area under the curve (AUC) 0 .77 -0 .99 , sensitivity 69 %-95 %, specificity 71 %-96 %)[15 -17 ]. In one of these studies, radiomics outperformed radiologic characteristics in differentiating MCNs and macrocystic SCAs; comparative diagnostic parameters included sensitivity (93 .6 % vs 74 .2 %), specificity (96 .2 % vs 80 .8 %) and accuracy (94 .7 % vs 77 .2 %), respectively[16 ]. Combining radiomics with radiological findings or clinical parameters significantly improved the accuracy to distinguish cyst types in comparison to radiomics alone (P< 0 .05 ) [16 ,18 ].

    Only a few studies have evaluated the role of radiomics in differentiating IPMNs with advanced neoplasia, from indolent lesions with low-grade dysplasia (Table 1 )[19 -23 ]. Most of the studies evaluating radiomics in IPMNs have used CT scans, and included patients with confirmed surgical histopathology as ground truth. A recent study by Cuiet al[24 ], presents the first publication where a radiomic signature incorporating 9 features was combined with clinical variables to predict high-grade dysplasia or adenocarcinoma (advanced neoplasia) in branch duct-IPMNs. Their predictive nomogram diagnosed advanced neoplasia with AUC values of 0 .903 (training cohort; sensitivity 95 %, specificity 73 %), and 0 .884 (one of two external validation cohorts; sensitivity 79 %, specificity 90 %)[24 ].

    Table 1 Summary of studies evaluating the role of radiomics in differentiating intraductal papillary mucinous neoplasms with advanced neoplasia

    HGD: High-grade dysplasia; LGD: Low-grade dysplasia; CECT: Contrast-enhanced computed tomography; MRI: Magnetic resonance imaging; mi-RNA:micro-RNA; DWI: Diffusion weighted imaging; AUC: Area under curve; SN: Sensitivity; SP: Specificity; NA: Not application.

    Thus, radiomics represents a promising non-invasive approach for the classification and risk stratification of PCLs and will favorably impact patient management.However, radiomics continues to be a novel concept and has been largely used to date in clinical trials at academic centers. While radiomics has demonstrated an immense potential for diagnosis, prognosis, and risk assessment in PCLs; there is a need for standardized protocols for image acquisition, segmentation, feature extraction, and analysis.

    TRADITIONAL DIAGNOSTIC APPROACHES USING BIOMARKERS

    Cyst fluid analysis

    CEA and amylase: Traditionally pancreatic cyst fluid is aspirated using EUS-FNA for biomarker and cytologic analysis. In early studies, cyst fluid CEA levels above 192 ng/mL was shown to correlate with mucinous PCL with 79 % (88 /111 ) accuracy (P<0 .0001 )[25 ]. However more recent studies, have estimated CEA sensitivity and specificity at 63 % and 88 %, respectively in differentiating mucinous from nonmucinous cysts[26 ]. This level of accuracy would result in misdiagnosis of 35 %-39 % of mucinous cysts. Additionally, CEA levels across sites are difficult to compare and levels have not been shown to correlate with PCL malignant potential[25 ,27 -29 ].Regarding amylase levels, a low cyst fluid amylase level has very high specificity for excluding pseudocyst. However, high amylase levels have been shown to have no diagnostic utility[26 ,30 ]. As a result, measuring amylase has fallen out of favor for the diagnosis of PCLs.

    Cytology: Cyst fluid analysis by cytology has been shown to lack sensitivity for the diagnosis of PCLs. A meta-analysis with 937 patients demonstrated cyst fluid cytology to have 63 % sensitivity and 88 % specificity for the diagnosis of PCL[31 ]. Another metaanalysis calculated cytology to have 51 % and 94 % sensitivity and specificity,respectively[32 ]. This lack of sensitivity results from cytology evaluations usually detecting only intact exfoliated cells that are typically few in number[25 ,33 ].Glucose:Intracystic glucose has good accuracy at differentiating mucinous and nonmucinous cysts but this economical diagnostic tool has not been used in routine clinical practice. However, recent prospective studies have provided improved and sustained evidence that cyst fluid glucose should be considered for standard of care evaluation of PCLs. Low intra-cystic glucose concentration is predictive of a mucinous cyst while high concentrations are consistent with non-mucinous cysts. In 2020 ,Ribaldoneet al[34 ] reported from 56 patients that intra-cystic glucose concentration <50 mg/dL had significantly better sensitivity than a CEA level > 192 ng/mL for diagnosing mucinous cysts (93 .6 % vs 54 .8 %; P = 0 .003 ). Both CEA and intra-cystic glucose had high specificity for diagnosing mucinous cysts (96 % vs 100 %; P = 1 ). They reported that intra-cystic glucose concentration of more than 50 mg/dL had higher sensitivity than CEA values of less than 5 ng/mL for diagnosing non-mucinous cysts(96 % vs 72 %, P = 0 .07 ).

    A meta-analysis of 7 studies encompassing 566 patients reported that lower (cut-off< 50 mg/dL) intra-cystic glucose concentration had a pooled sensitivity of 90 .1 %(95 %CI: 87 .2 -92 .5 ) and pooled specificity of 85 .3 % (95 %CI: 76 .8 -91 .1 ) when differentiating mucinous from non-mucinous cysts[35 ]. In a subset analysis, point-of-care glucometer measurements for intra-cystic glucose (3 studies) also revealed comparable pooled sensitivity of 89 .5 % (95 %CI: 85 .5 -92 .5 ; I2 = 0 ) and pooled specificity of 83 .9 %(95 %CI: 68 .5 -92 .6 ; I2 = 43 ) for the differentiation of PCLs[35 ]. A more recent (2021 )meta-analysis that included 8 studies with 609 PCLs showed pooled sensitivities for glucosevsCEA of 91 % (95 %CI: 88 -94 ) vs 56 % (95 %CI 46 -66 ) (comparativePvalue <0 .001 ), pooled specificities were 86 % (95 %CI: 81 -90 ) vs 96 % (95 %CI: 90 -99 ), P > 0 .05 ,respectively[36 ].

    Estimation of glucose levels is a low-cost diagnostic test that has repeatedly demonstrated better accuracy at differentiating mucinous and non-mucinous cyst.While not being definitive, cyst fluid glucose is a practical and economical diagnostic tool that can help in the differentiation of PCLs.

    Molecular markers: With the introduction of next-generation sequencing (NGS),diagnosis of PCLs with either small gene panels and whole exome NGS have been employed. This method allows assessment of intact cell and cell-free nucleic acid that has been shed into the cyst fluid. DNA mutations that are commonly associated with pancreatic adenocarcinoma (KRAS, CDKN2A, SMAD4 , PTEN, PIK3 CA, and TP53 ) may also be present in precursor PCLs, with the latter five associated with advanced neoplasia.

    Similar to radiomics, molecular analysis of cyst fluid can contribute to the classification of PCLs, and risk stratification of IPMNs. In a meta-analysis (6 studies, 785 PCLs), McCartyet al[37 ] reported that the dual presence ofKRASandGNASmutations detected mucinous PCLs with a sensitivity of 75 % (95 %CI: 58 -87 %), specificity of 99 %(95 %CI: 67 -100 %), and diagnostic accuracy of 97 % (95 %CI: 95 -98 %), respectively. For specifically diagnosing IPMNs, dualKRAS/GNASmutation had 94 % (95 %CI: 72 -99 %)sensitivity, 91 % (95 %CI: 72 -98 ; I2 = 89 .83 %) specificity and 97 % (95 %CI: 95 -98 %)accuracy, respectively. Recently, our group identified, for the first time, that uncommonBRAFmutations (and occasionalMAP2K1mutations) characterize a significant subset of IPMNs that lackKRASmutations, indicating that RAS-MAPK dysregulation is ubiquitous in these tumors[12 ]. In the same study, we showed 88 .5 %sensitivity, 100 % specificity, and 90 .3 % accuracy for NGS differentiation of PCLs[12 ].

    For the risk stratification of IPMNs, Singhiet al[38 ] used next-generation sequencing to evaluate DNA mutations associated with advanced neoplasia. In a subgroup analysis of 102 patients with histopathologic diagnosis, they reported that the presence of TP53 , PIK3 CA and/or PTEN mutation had 88 % (95 %CI: 62 -98 %) sensitivity and 95 % (95 %CI: 88 -98 %) specificity, respectively for diagnosing IPMNs with advanced neoplasia.

    Cyst fluid molecular analysis by next generation sequencing is superior to measuring cyst CEA levels with superior accuracy and the ability to provide risk stratification for IPMNs. However, it is selectively available and represents a logistical and financial barrier for universal adaptation.

    ADVANCED INTERVENTIONAL DIAGNOSTIC APPROACHES

    EUS-guided needle confocal laser endomicroscopy

    EUS-guided needle confocal laser endomicroscopy (nCLE) permits real-time microscopic imaging of intra-cystic epithelium within a single plane. It allows forinvivopathological analysis of PCLs. Early studies have established the characteristic features for IPMNs. Investigations by Napoleonet al[40 ] in the CONTACT study established defining criteria for MCNs, SCAs, and cystic neuroendocrine tumors[39 ,40 ]. In 2020 , the INDEX study provided further support for nCLE as a viable diagnostic tool by demonstrating high performance in differentiating PCLs amongst the highest number (n= 65 ) of patients with surgical histopathology[41 ]. For the differentiation of PCLs into mucinous and non-mucinous lesions, a recent meta-analysis with 7 studies and 324 patients reported a pooled sensitivity, specificity and accuracy of 85 % (95 %CI: 71 -93 %), 99 % (95 %CI: 90 -100 %) and 99 % (95 %CI: 98 -100 %),respectively. The pooled risk of post-procedure acute pancreatitis was 1 % (95 %CI: 0 -3 %)[42 ]. Another recent meta-analysis (10 studies, 536 patients) reported a pooled sensitivity, specificity, and accuracy of 82 .4 % (95 %CI: 74 .7 -90 .1 %), 96 .6 % (95 %CI: 94 .3 -99 %), and 88 .6 % (95 %CI: 83 .7 -93 .4 %), respectively, for the differentiation of mucinous from non-mucinous PCLs[43 ].

    In addition to the high accuracy of diagnosing IPMNs and other cysts, nCLE can potentially determine the risk for advanced neoplasia in PCLs. To detect advanced neoplasia in IPMNs, multiple nCLE imaging variables were identified in a post-hoc analysis of the INDEX study[44 ], Figure 2 . This study identified that the variables with the highest interobserver agreement were papillary epithelial thickness and darkness.Specifically, nCLE visualized papillary epithelial thickness (width ≥ 50 μm) had a sensitivity, specificity, and AUC of 87 .5 % (95 %CI: 62 %-99 %), 100 % (95 %CI: 69 %-100 %),and 0 .95 , respectively for the detection of advanced neoplasia. Also, estimation of the papillary epithelial darkness (cut-off ≤ 90 pixel intensity) revealed a sensitivity,specificity, and AUC of 87 .5 % (95 %CI: 62 %-99 %), 100 % (95 %CI: 69 %-100 %), and 0 .90 ,respectively[44 ]. Analogously for mucinous cysts, Feng et al[45 ] reported that nCLE pattern of “dark aggregates of neoplastic cells” correlated with the morphologic features of "irregular branching and budding" and was diagnostic of malignancy, with 75 % sensitivity, 100 % specificity and 94 % accuracy, respectively.

    However, potential limitations of nCLE include differences in interobserver interpretation of images and the tedious nature of manually determining papillary epithelial thickness and darkness. Both of these issues were addressed with the development of a machine learning artificial intelligence model that identified advanced neoplasia in IPMNs with a sensitivity (83 %) and specificity (88 %) well above the Fukuoka or AGA guidelines[46 ].

    Despite the growing evidence of nCLE as a viable diagnostic technique, its incorporation into standard clinical evaluation is lacking. The primary challenges include equipment costs, optimal training in image acquisition and interpretation, and prevention of adverse events higher than the standard EUS-FNA process.

    EUS guided MFB or EUS-through-the-needle biopsy

    This technique utilizes an EUS guided approach to pass a specialized device, the Moray micro forceps (Moray micro forceps, US Endoscopy, Mentor, Ohio, United States) through the 19 -gauge EUS needle to collect tissue sample from PCLs. Multiple recent studies have demonstrated an improved diagnostic yield and accuracy in the diagnosis of specific types of PCLs[47 ,48 ].

    Multiple meta-analyses have been published and the most recent studies include the following. Tacelliet al[49 ] (2020 ) included 9 studies with 454 patients and pooled technical success, histological accuracy and diagnostic yield for specific types of PCLs were 98 .5 % (95 %CI: 97 .3 %-99 .6 %), 86 .7 % (95 %CI: 80 .1 -93 .4 ) and 69 .5 % (95 %CI: 59 .2 -79 .7 %), respectively. Additionally sensitivity and specificity for diagnosis of mucinous PCLs were 88 .6 % and 94 .7 %, respectively. However, the overall complication rate was 8 .6 % (95 %CI: 4 .0 -13 .1 %) with studies reporting rates ranging from 1 %-23 %. Of the reported complications, 57 .1 % had self-limiting bleedings (most commonly intra-cystic bleeding), 24 .5 % had mild pancreatitis, 6 .1 % had infections and 14 .3 % had abdominal pain. Westerveldet al[50 ] analyzed 8 studies with 426 patients reporting similar results. The MFB approach had significantly higher diagnostic yield for specific cyst type compared to cytology (72 .5 %, 95 %CI: 60 .6 -83 .0 % vs 38 .1 %, 95 %CI: 18 .0 -60 .5 %).Additionally, MFB had significantly higher diagnostic yield for mucinous cyst compared to cytology (OR: 3 .86 ; 95 %CI: 2 .0 -7 .44 , I2 = 72 %). Overall MFB procedures had a 7 % complication rate with 5 % incidence of intra-cystic hemorrhage and 2 .3 % risk of acute pancreatitis. More importantly, in a subgroup analysis of 92 patients who had surgical resection of their PCLs, MFB findings had concordance of 82 .3 % (95 %CI: 71 .9 -90 .7 %) for specific cyst diagnosis. MFB findings for mucinous cysts had a sensitivity of 90 .1 % (95 %CI: 78 .4 -97 .6 %) and specificity of 94 % (95 %CI: 81 .5 -99 .7 %). Additionally,the concordance rate for histological grade of dysplasia was 75 .6 % (95 %CI: 62 .3 -86 .8 ).

    Figure 2 Features identified on endoscopic ultrasound guided needle confocal laser endomicroscopy. IPMN: Intraductal papillary mucinous neoplasms.

    In another meta-analysis that included patients with surgical histopathology as reference diagnosis, the pooled sensitivity and specificity for diagnosing mucinous PCL was 86 % (95 %CI: 62 -96 %) and specificity 95 % (95 %CI: 79 -99 %) respectively[51 ].For diagnosis of specific cyst type, the pooled sensitivity and specificity were 69 %(95 %CI: 50 -83 %) and specificity 47 % (95 %CI: 28 -68 %), respectively. The authors also grouped IPMNs and MCNs with advanced neoplasia, SPNs, and cystic neuroendocrine tumors as high-risk cysts. MFB demonstrated a pooled sensitivity and specificity of 78 % (95 %CI: 61 -89 %) and 99 % (95 %CI: 90 -99 %) respectively for diagnosis of a high-risk cyst.

    While MFB represents an excellent technique for acquisition of tissue and accurately diagnosing PCLs, the high rates of adverse events including acute pancreatitis and intra-cystic bleeding may deter clinicians from using this technique.

    Contrast-enhanced EUS

    EUS when combined with contrast enhancers allows detection of vascularity within PCLs. This allowed contrast-enhanced EUS (CE-EUS) to differentiate pseudocysts from true PCLs and identify mural nodules within PCLs. Despite early studies reporting no improvement over traditional EUS at differentiating PCLs[52 ], recent studies have reported higher diagnostic yield for PCLs using CE-EUS (96 % compared to 71 % for traditional EUS)[53 ]. CE-EUS detected small lesions initially missed on contrast-enhanced CT or EUS-FNA[54 ]. Recent literature on CE-EUS has reported higher accuracy at diagnosing PCLs compared to CT, MRI and traditional EUS[55 ].Despite these encouraging results, CE-EUS has not gained traction in clinical management of PCLs.

    CONCLUSION

    Future directions in the diagnosis of pancreatic cysts

    Reliable and accurate diagnosis of PCLs is a bottleneck for appropriate management of these lesions. Although, novel diagnostics have improved the diagnostic accuracy,there is still a dearth of prospective multicenter studies and a need to understand the complementary role of these tests. Radiomics, as a non-invasive tool has the potential for preliminary risk stratification of PCLs into low-and-high risk lesions (Figure 3 ). The technique holds a potential to allow clinicians to skip expensive and invasive diagnostic techniques on certain low risk PCLs.

    For low-risk PCLs, and when EUS-FNA is indicated, low-cost cyst fluid analysis with glucose, CEA, and cytology can guide management (Figure 3 ). If radiomics and EUS cyst morphology are indicative of a high-risk PCL, advanced diagnostics with cyst fluid molecular analysis, nCLE, or microforceps biopsy can be considered based on the center and endoscopists’ expertise. The rate of adverse events with microforceps biopsy needs to be considered when considering this test.

    Figure 3 Future directions of detection and risk stratification of pancreatic cystic lesion to guide clinical management. PCL: Pancreatic cystic lesion, CEA: Carcinoembryonic antigen, IPMN: Intraductal papillary mucinous neoplasms.

    Despite the availability of multiple diagnostic methods, the diagnosis and management of PCLs continues to be challenging. The more recent diagnostic modalities lack supportive larger multicenter data and there is need to demonstrate cost-effectiveness when compared to using suboptimal techniques and resultant unwarranted resection of otherwise benign or indolent PCLs. Apart from diagnosis,surveillance methods for low-risk lesions needs innovation as current tools are resource-consumptive.

    国产av精品麻豆| 五月开心婷婷网| 国产成人精品久久久久久| 日本色播在线视频| 亚洲情色 制服丝袜| 老司机影院成人| 女人高潮潮喷娇喘18禁视频| 国产三级黄色录像| 亚洲欧美成人综合另类久久久| svipshipincom国产片| 少妇猛男粗大的猛烈进出视频| 在线观看www视频免费| 国产欧美日韩一区二区三 | 国产在线视频一区二区| 别揉我奶头~嗯~啊~动态视频 | 亚洲熟女毛片儿| av欧美777| 成年美女黄网站色视频大全免费| 最新在线观看一区二区三区 | 国产伦理片在线播放av一区| 国产精品一国产av| 久久青草综合色| 一区二区三区激情视频| 久久亚洲国产成人精品v| 美女大奶头黄色视频| 两人在一起打扑克的视频| 国产免费视频播放在线视频| 午夜视频精品福利| 视频区欧美日本亚洲| 欧美日韩福利视频一区二区| 精品国产国语对白av| 狠狠精品人妻久久久久久综合| 亚洲精品美女久久久久99蜜臀 | 丝瓜视频免费看黄片| 男女床上黄色一级片免费看| 国产欧美亚洲国产| 色94色欧美一区二区| 少妇裸体淫交视频免费看高清 | 国产在线免费精品| 日韩,欧美,国产一区二区三区| avwww免费| 久久久国产精品麻豆| 久久九九热精品免费| 国产高清国产精品国产三级| 蜜桃国产av成人99| av有码第一页| 18禁黄网站禁片午夜丰满| 亚洲精品国产色婷婷电影| 亚洲精品日本国产第一区| 欧美av亚洲av综合av国产av| 大话2 男鬼变身卡| 色综合欧美亚洲国产小说| 中文字幕高清在线视频| 91九色精品人成在线观看| 欧美日韩视频精品一区| 无遮挡黄片免费观看| 国产成人欧美| 成年av动漫网址| 午夜福利,免费看| 亚洲人成电影观看| 国产日韩一区二区三区精品不卡| 亚洲五月色婷婷综合| 久久亚洲精品不卡| 电影成人av| √禁漫天堂资源中文www| a级毛片黄视频| 日韩电影二区| 国产精品偷伦视频观看了| 亚洲国产精品一区三区| 每晚都被弄得嗷嗷叫到高潮| 国产高清不卡午夜福利| 在线av久久热| 九色亚洲精品在线播放| 在线精品无人区一区二区三| 七月丁香在线播放| av电影中文网址| 亚洲国产成人一精品久久久| 天天躁狠狠躁夜夜躁狠狠躁| 日本一区二区免费在线视频| 亚洲视频免费观看视频| 少妇精品久久久久久久| 一区福利在线观看| 蜜桃国产av成人99| 午夜福利乱码中文字幕| 看免费成人av毛片| 国产精品久久久久久人妻精品电影 | 亚洲一卡2卡3卡4卡5卡精品中文| 亚洲国产欧美在线一区| 久久 成人 亚洲| 亚洲精品一卡2卡三卡4卡5卡 | 另类精品久久| 欧美在线黄色| 精品久久久久久久毛片微露脸 | 精品一品国产午夜福利视频| 黄频高清免费视频| 欧美激情高清一区二区三区| 国产精品av久久久久免费| 国产av精品麻豆| 交换朋友夫妻互换小说| 久久九九热精品免费| 在线av久久热| 亚洲色图综合在线观看| 成年av动漫网址| 人体艺术视频欧美日本| 18禁裸乳无遮挡动漫免费视频| 亚洲精品日本国产第一区| 国产午夜精品一二区理论片| 香蕉国产在线看| 亚洲国产精品一区三区| 女人高潮潮喷娇喘18禁视频| 亚洲黑人精品在线| 国产成人av激情在线播放| 天天躁夜夜躁狠狠躁躁| 国产欧美日韩精品亚洲av| 精品福利永久在线观看| 一级片免费观看大全| 免费高清在线观看视频在线观看| 爱豆传媒免费全集在线观看| 成人18禁高潮啪啪吃奶动态图| 亚洲国产欧美网| 在现免费观看毛片| 亚洲成人免费电影在线观看 | 成人手机av| 18禁黄网站禁片午夜丰满| 婷婷丁香在线五月| 亚洲精品久久午夜乱码| 亚洲欧美精品综合一区二区三区| 亚洲成人国产一区在线观看 | 波多野结衣av一区二区av| 满18在线观看网站| 久久ye,这里只有精品| 国产无遮挡羞羞视频在线观看| 看十八女毛片水多多多| 日本猛色少妇xxxxx猛交久久| 久久久久国产精品人妻一区二区| 国产三级黄色录像| 日本猛色少妇xxxxx猛交久久| 一区二区三区激情视频| 久久人妻福利社区极品人妻图片 | 中文字幕人妻丝袜一区二区| 亚洲伊人久久精品综合| 国产亚洲av高清不卡| 久久精品国产亚洲av涩爱| 99热国产这里只有精品6| 黄色毛片三级朝国网站| 日韩免费高清中文字幕av| 中文字幕亚洲精品专区| 黄色a级毛片大全视频| 亚洲精品久久午夜乱码| 王馨瑶露胸无遮挡在线观看| 在线 av 中文字幕| 久久久久久久国产电影| 欧美av亚洲av综合av国产av| www.av在线官网国产| 久久免费观看电影| 免费久久久久久久精品成人欧美视频| 久久久精品区二区三区| 丝袜美腿诱惑在线| 9色porny在线观看| 晚上一个人看的免费电影| 亚洲男人天堂网一区| 欧美亚洲 丝袜 人妻 在线| 国产高清videossex| 久久久久久久久免费视频了| 蜜桃在线观看..| 亚洲中文av在线| 成人手机av| 亚洲成国产人片在线观看| 亚洲,一卡二卡三卡| 校园人妻丝袜中文字幕| 九色亚洲精品在线播放| 免费少妇av软件| 国产精品.久久久| 亚洲色图 男人天堂 中文字幕| 亚洲av男天堂| 大片免费播放器 马上看| 免费在线观看视频国产中文字幕亚洲 | 在线观看免费午夜福利视频| 成人18禁高潮啪啪吃奶动态图| 久久国产精品影院| 涩涩av久久男人的天堂| 十八禁网站网址无遮挡| 19禁男女啪啪无遮挡网站| 亚洲欧美日韩另类电影网站| 国产精品免费视频内射| 成年av动漫网址| 国产欧美日韩精品亚洲av| 日韩av在线免费看完整版不卡| 一级毛片 在线播放| 啦啦啦在线免费观看视频4| 成年av动漫网址| 亚洲国产精品一区二区三区在线| 91精品伊人久久大香线蕉| 亚洲欧美一区二区三区国产| 美女国产高潮福利片在线看| 黄频高清免费视频| 九草在线视频观看| 亚洲国产欧美一区二区综合| 老司机午夜十八禁免费视频| 少妇的丰满在线观看| 欧美精品av麻豆av| 中文字幕精品免费在线观看视频| 免费在线观看影片大全网站 | 久久国产精品大桥未久av| 日本午夜av视频| 国产一区有黄有色的免费视频| 十八禁人妻一区二区| 在线观看免费高清a一片| 在线观看一区二区三区激情| 免费观看a级毛片全部| 一本大道久久a久久精品| 宅男免费午夜| 自拍欧美九色日韩亚洲蝌蚪91| 国产无遮挡羞羞视频在线观看| 中文字幕人妻丝袜制服| 国产成人a∨麻豆精品| 日韩视频在线欧美| 免费在线观看黄色视频的| 亚洲一区中文字幕在线| 波野结衣二区三区在线| av国产精品久久久久影院| 在线观看一区二区三区激情| 国产极品粉嫩免费观看在线| 亚洲欧美精品综合一区二区三区| 久久国产精品大桥未久av| 国产精品一区二区在线不卡| 国产真人三级小视频在线观看| 别揉我奶头~嗯~啊~动态视频 | 午夜福利乱码中文字幕| 在线av久久热| av线在线观看网站| 制服诱惑二区| 亚洲三区欧美一区| 久久久久久久久久久久大奶| 黄片播放在线免费| 免费少妇av软件| 最黄视频免费看| 九色亚洲精品在线播放| 欧美激情高清一区二区三区| 午夜免费鲁丝| 国产精品久久久人人做人人爽| 日韩一卡2卡3卡4卡2021年| 日韩一区二区三区影片| 国产精品 国内视频| 热re99久久国产66热| 亚洲成人国产一区在线观看 | 亚洲第一青青草原| 91麻豆av在线| 精品亚洲乱码少妇综合久久| 美女主播在线视频| 99热全是精品| 日韩一本色道免费dvd| 亚洲成人手机| 捣出白浆h1v1| 国产高清国产精品国产三级| 久热这里只有精品99| 18禁黄网站禁片午夜丰满| 日韩一区二区三区影片| 日韩av不卡免费在线播放| 一本综合久久免费| 午夜福利免费观看在线| 免费在线观看日本一区| 亚洲男人天堂网一区| 高清av免费在线| 久久久久久久国产电影| 久9热在线精品视频| 午夜激情av网站| 人体艺术视频欧美日本| 精品卡一卡二卡四卡免费| 国产成人一区二区在线| 免费久久久久久久精品成人欧美视频| 日本欧美视频一区| 国产精品亚洲av一区麻豆| 老汉色∧v一级毛片| 99精国产麻豆久久婷婷| 亚洲精品自拍成人| 国产又爽黄色视频| 1024视频免费在线观看| 两个人看的免费小视频| 精品少妇一区二区三区视频日本电影| 两个人免费观看高清视频| 久久性视频一级片| 久久久久久久精品精品| 国产亚洲av高清不卡| 熟女av电影| 精品国产一区二区久久| 每晚都被弄得嗷嗷叫到高潮| 国产精品国产三级专区第一集| 亚洲中文日韩欧美视频| 女人久久www免费人成看片| 国产精品一区二区在线不卡| 青春草视频在线免费观看| 日本vs欧美在线观看视频| 另类精品久久| 如日韩欧美国产精品一区二区三区| 一边摸一边抽搐一进一出视频| 五月开心婷婷网| 午夜久久久在线观看| 97在线人人人人妻| av片东京热男人的天堂| av在线app专区| 亚洲五月婷婷丁香| 超碰成人久久| 男女无遮挡免费网站观看| 成在线人永久免费视频| 亚洲精品一区蜜桃| 久久精品国产亚洲av涩爱| 两性夫妻黄色片| 午夜福利影视在线免费观看| 免费高清在线观看日韩| 午夜福利视频精品| 美女高潮到喷水免费观看| 伦理电影免费视频| 天天影视国产精品| 色综合欧美亚洲国产小说| 午夜免费成人在线视频| 国产麻豆69| 三上悠亚av全集在线观看| 亚洲五月婷婷丁香| 亚洲中文字幕日韩| 最新的欧美精品一区二区| 国产片特级美女逼逼视频| 美女脱内裤让男人舔精品视频| 亚洲,一卡二卡三卡| 欧美激情 高清一区二区三区| 国产麻豆69| 一级a爱视频在线免费观看| 亚洲图色成人| 国产精品99久久99久久久不卡| 国产精品麻豆人妻色哟哟久久| 大陆偷拍与自拍| 欧美日韩亚洲综合一区二区三区_| 亚洲av欧美aⅴ国产| 国产日韩一区二区三区精品不卡| 午夜精品国产一区二区电影| 在线看a的网站| 久久国产亚洲av麻豆专区| 欧美日本中文国产一区发布| 久久久久久久久免费视频了| 亚洲国产精品999| 精品欧美一区二区三区在线| 亚洲第一av免费看| 国产一区亚洲一区在线观看| 男女无遮挡免费网站观看| 国产成人欧美在线观看 | 国产精品一国产av| 欧美亚洲日本最大视频资源| 免费高清在线观看视频在线观看| 亚洲成人免费电影在线观看 | 韩国精品一区二区三区| 国产成人一区二区三区免费视频网站 | 国产伦理片在线播放av一区| 9色porny在线观看| 欧美人与善性xxx| 中国国产av一级| av视频免费观看在线观看| 婷婷丁香在线五月| 久久精品aⅴ一区二区三区四区| 精品欧美一区二区三区在线| 欧美大码av| av天堂在线播放| 欧美日韩一级在线毛片| 国产爽快片一区二区三区| 视频在线观看一区二区三区| 久久久久国产精品人妻一区二区| 亚洲五月婷婷丁香| 亚洲av综合色区一区| 18在线观看网站| 亚洲欧美激情在线| 国产精品偷伦视频观看了| 亚洲欧美激情在线| 十八禁人妻一区二区| 日本欧美国产在线视频| 大型av网站在线播放| 一边摸一边抽搐一进一出视频| 亚洲欧美一区二区三区黑人| 久久精品亚洲熟妇少妇任你| 国产精品 国内视频| 丝袜脚勾引网站| 高清黄色对白视频在线免费看| 五月天丁香电影| 久久精品国产亚洲av高清一级| 一级毛片我不卡| 天天添夜夜摸| 婷婷色综合www| 午夜福利免费观看在线| 亚洲国产最新在线播放| 色网站视频免费| 欧美乱码精品一区二区三区| 国产熟女欧美一区二区| 欧美 亚洲 国产 日韩一| 黄频高清免费视频| 亚洲午夜精品一区,二区,三区| 母亲3免费完整高清在线观看| 午夜激情av网站| 国产精品 国内视频| 一级a爱视频在线免费观看| 久久免费观看电影| 亚洲中文字幕日韩| 精品国产乱码久久久久久小说| 在线观看www视频免费| 日本av免费视频播放| 欧美日韩亚洲高清精品| 欧美日韩福利视频一区二区| 精品人妻一区二区三区麻豆| 精品欧美一区二区三区在线| 日韩欧美一区视频在线观看| av天堂久久9| 国产又色又爽无遮挡免| 亚洲国产精品一区三区| 国产一区二区激情短视频 | 人人妻,人人澡人人爽秒播 | 狠狠精品人妻久久久久久综合| 日本一区二区免费在线视频| 极品少妇高潮喷水抽搐| 91麻豆av在线| 国产精品久久久人人做人人爽| 亚洲精品国产色婷婷电影| 欧美黑人欧美精品刺激| 日日摸夜夜添夜夜爱| 国产三级黄色录像| 欧美人与性动交α欧美软件| 国产福利在线免费观看视频| 精品少妇一区二区三区视频日本电影| 观看av在线不卡| 男人舔女人的私密视频| 狂野欧美激情性xxxx| 欧美97在线视频| 夫妻午夜视频| 一二三四社区在线视频社区8| 亚洲精品av麻豆狂野| 色94色欧美一区二区| 亚洲国产最新在线播放| 免费女性裸体啪啪无遮挡网站| 国产精品久久久久久精品电影小说| 久久免费观看电影| 日韩中文字幕欧美一区二区 | 少妇精品久久久久久久| 亚洲欧洲日产国产| 中文字幕人妻丝袜一区二区| 黄色毛片三级朝国网站| 日本a在线网址| 一边摸一边抽搐一进一出视频| 亚洲av欧美aⅴ国产| 国产精品一二三区在线看| 欧美精品一区二区免费开放| 久久久久久久大尺度免费视频| 国产欧美日韩综合在线一区二区| 日本91视频免费播放| 国产精品人妻久久久影院| 青春草视频在线免费观看| 男女国产视频网站| 国产在线视频一区二区| 捣出白浆h1v1| 涩涩av久久男人的天堂| 永久免费av网站大全| 国产成人啪精品午夜网站| 中文字幕亚洲精品专区| 香蕉国产在线看| 999久久久国产精品视频| 91国产中文字幕| av不卡在线播放| 韩国高清视频一区二区三区| 亚洲成人国产一区在线观看 | 欧美日韩av久久| 波野结衣二区三区在线| 丰满迷人的少妇在线观看| 久久精品国产亚洲av涩爱| 中文字幕高清在线视频| 亚洲一码二码三码区别大吗| 国产亚洲一区二区精品| 亚洲欧美成人综合另类久久久| 搡老岳熟女国产| 欧美另类一区| 久久久久精品人妻al黑| 天天躁日日躁夜夜躁夜夜| 香蕉丝袜av| 午夜激情av网站| 两性夫妻黄色片| 狠狠精品人妻久久久久久综合| 日韩大片免费观看网站| 免费黄频网站在线观看国产| 一区二区av电影网| 久热爱精品视频在线9| 亚洲专区中文字幕在线| 男女边摸边吃奶| 欧美国产精品va在线观看不卡| 欧美日韩综合久久久久久| av又黄又爽大尺度在线免费看| 女人被躁到高潮嗷嗷叫费观| 大型av网站在线播放| 在线看a的网站| 日日夜夜操网爽| 欧美老熟妇乱子伦牲交| 极品人妻少妇av视频| 老司机靠b影院| 久久精品成人免费网站| 精品国产国语对白av| 精品久久久久久久毛片微露脸 | 久久精品久久久久久噜噜老黄| 欧美日韩黄片免| 两性夫妻黄色片| 久久久精品区二区三区| 久久精品亚洲av国产电影网| 18禁观看日本| 亚洲综合色网址| 亚洲久久久国产精品| 色播在线永久视频| 日韩av在线免费看完整版不卡| 欧美 日韩 精品 国产| 性少妇av在线| 1024香蕉在线观看| 99久久99久久久精品蜜桃| 母亲3免费完整高清在线观看| 999精品在线视频| 久久久久久亚洲精品国产蜜桃av| 欧美激情 高清一区二区三区| 丝袜美足系列| 天天操日日干夜夜撸| 激情视频va一区二区三区| 亚洲伊人久久精品综合| av视频免费观看在线观看| av在线播放精品| 你懂的网址亚洲精品在线观看| 一级黄片播放器| 国产成人一区二区三区免费视频网站 | 国产成人精品久久二区二区91| 韩国高清视频一区二区三区| 99热网站在线观看| 久久久欧美国产精品| 中文字幕高清在线视频| 亚洲精品自拍成人| 精品人妻1区二区| 亚洲成国产人片在线观看| 国产在线观看jvid| 一级片'在线观看视频| 国产成人免费无遮挡视频| 国产不卡av网站在线观看| 丰满人妻熟妇乱又伦精品不卡| 日本91视频免费播放| 久久久久久亚洲精品国产蜜桃av| 精品人妻1区二区| 精品国产一区二区久久| 成年av动漫网址| 少妇的丰满在线观看| 午夜福利乱码中文字幕| 亚洲国产中文字幕在线视频| 久久亚洲精品不卡| 亚洲精品国产一区二区精华液| 女人高潮潮喷娇喘18禁视频| 麻豆国产av国片精品| 建设人人有责人人尽责人人享有的| 色精品久久人妻99蜜桃| 色婷婷久久久亚洲欧美| 久久人妻熟女aⅴ| 欧美性长视频在线观看| 男女之事视频高清在线观看 | 老司机深夜福利视频在线观看 | 看免费成人av毛片| 久久ye,这里只有精品| 午夜福利一区二区在线看| 可以免费在线观看a视频的电影网站| 欧美+亚洲+日韩+国产| 操出白浆在线播放| 亚洲中文字幕日韩| 亚洲精品自拍成人| 欧美精品亚洲一区二区| 久久99一区二区三区| 女人爽到高潮嗷嗷叫在线视频| 波野结衣二区三区在线| 免费一级毛片在线播放高清视频 | 香蕉丝袜av| 99九九在线精品视频| 成人亚洲精品一区在线观看| 久久国产亚洲av麻豆专区| 国产在线视频一区二区| 91老司机精品| 一本一本久久a久久精品综合妖精| 欧美少妇被猛烈插入视频| 国产免费又黄又爽又色| 2018国产大陆天天弄谢| 国产xxxxx性猛交| 色婷婷av一区二区三区视频| av线在线观看网站| 操出白浆在线播放| 纯流量卡能插随身wifi吗| 欧美精品一区二区免费开放| 亚洲精品国产区一区二| 日韩av在线免费看完整版不卡| 欧美成人午夜精品| 欧美亚洲 丝袜 人妻 在线| 久久人人爽人人片av| 在线观看免费日韩欧美大片| 国产无遮挡羞羞视频在线观看| 香蕉国产在线看| 精品人妻一区二区三区麻豆| 久久ye,这里只有精品| 一级毛片黄色毛片免费观看视频| 天堂俺去俺来也www色官网| 一级片'在线观看视频| videosex国产| 国产日韩欧美视频二区| 久久久久视频综合| 国产成人一区二区在线| 老司机在亚洲福利影院| 亚洲人成电影免费在线| avwww免费| 精品卡一卡二卡四卡免费| 丝袜人妻中文字幕| 国产日韩欧美亚洲二区| 亚洲 欧美一区二区三区| 日韩一本色道免费dvd| 少妇精品久久久久久久| 亚洲欧美日韩高清在线视频 | 欧美日本中文国产一区发布|